METHODS FOR ENHANCING THE EFFICACY OF VASCULAR DISRUPTING AGENTS
摘要
<p>This invention relates to methods for treating, preventing and/or managing cancer in a subject including enhacing the efficacy of a Vascular Disrupting Agent (e.g., a combretastatin or derivative thereof) by administering to the subject an a4ß1 integrin antagonist sequentially or simultaneously in combination with said Vascular Disrupting Agent.</p>
